Impact of COVID-19 on mental health of health care workers in Spain: a mix-methods study.

Publication date: Feb 14, 2024

Spain’s lockdown measures couldn’t prevent the severe impact of the COVID-19 first wave, leading to high infections, deaths, and strain on healthcare workers (HCWs). This study aimed to explore the mental health impact on HCWs in the Balearic Islands during the initial months of the pandemic, the influencing factors, and the experiences of those in a COVID-19 environment. Using a mixed-methods approach, the study encompassed quantitative and qualitative elements. Cross-sectional survey data from April to June 2020 comprised HCWs who were emailed invitations. The survey covered demographics, work, clinical and COVID-19 variables, along with psychological distress and PTSD symptoms, using validated measures. Additionally, semi-structured interviews with HCWs offered qualitative insights. Three hundred thirty-six HCWs averaging 46. 8 years, mainly women (79. 2%), primarily nurses in primary care with over 10 years of experience. Anxiety symptoms were reported by 28. 8%, 65. 1% noted worsened sleep quality, and 27. 7% increased psychoactive drug usage. Psychological distress affected 55. 2%, while 27. 9% exhibited PTSD symptoms. Gender, age, experience, COVID-19 patient contact, and workload correlated with distress, PTSD symptoms, sleep quality, and psychoactive drug usage. Interviews uncovered discomfort sources, such as fear of infection and lack of control, leading to coping strategies like information avoidance and seeking support. Static cross-sectional design, non-probabilistic sample, and telephone interviews affecting non-verbal cues, with interviews conducted during early pandemic lockdown. HCWs faced significant psychological distress during the pandemic’s first wave, underscoring the necessity for robust support and resources to counteract its impact on mental health.

Open Access PDF

Concepts Keywords
10years Background
Covid COVID-19
June Health care workers
Nurses Mental health
Pandemic Mix methods


Type Source Name
disease MESH COVID-19
disease MESH infections
disease MESH psychological distress
disease MESH PTSD
disease MESH sleep quality
disease IDO infection
disease VO LACK
pathway REACTOME Reproduction
disease VO organization
disease MESH emergency
disease MESH uncertainty
disease MESH acute stress disorder
disease MESH burnout
disease MESH morbidity
disease MESH death
drug DRUGBANK Etoperidone
drug DRUGBANK Coenzyme M
disease MESH work related stress
disease VO population
drug DRUGBANK Ethanol
disease MESH insomnia
disease VO report
disease VO frequency
disease IDO quality
disease VO USA
disease IDO process
drug DRUGBANK Serine
disease MESH shock
drug DRUGBANK Polyethylene glycol
drug DRUGBANK Trestolone
disease VO protocol
drug DRUGBANK Nonoxynol-9
disease VO Thing
disease MESH panic attacks
drug DRUGBANK Alprazolam
disease MESH mental disorder
drug DRUGBANK Indoleacetic acid
disease MESH sleep disorders
disease VO time
drug DRUGBANK Pirenzepine
drug DRUGBANK L-Valine
drug DRUGBANK Allylestrenol
drug DRUGBANK Modafinil
drug DRUGBANK Carboxyamidotriazole
disease MESH compassion fatigue
disease MESH syndrome
drug DRUGBANK Guanosine
disease MESH Piedra
disease IDO intervention

Original Article

(Visited 1 times, 1 visits today)